141 related articles for article (PubMed ID: 7990823)
1. [Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin].
Kiselev OI; Mishin VP; Eroshkin VI; Kozeletskaia KN; Usova EV; Rudenko VI; Chupakhin ON
Mol Biol (Mosk); 1994; 28(5):1009-13. PubMed ID: 7990823
[TBL] [Abstract][Full Text] [Related]
2. [The change in functional activity and primary structure of the M2 protein in variants of the influenza virus resistant to remantadine and deitiforin: common and individual differences from the original strain].
Kozeletskaia KN; Blinov VM; Karginov VA; Burmistrova VV; Siniakov AN; Golubev DB
Mol Gen Mikrobiol Virusol; 1989 Jun; (6):33-8. PubMed ID: 2811900
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
[TBL] [Abstract][Full Text] [Related]
4. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
Wang JF; Wei DQ; Chou KC
Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of rimantadine resistance in field isolates of influenza A viruses.
Ziegler T; Hemphill ML; Ziegler ML; Perez-Oronoz G; Klimov AI; Hampson AW; Regnery HL; Cox NJ
J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115
[TBL] [Abstract][Full Text] [Related]
6. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
Gu RX; Liu LA; Wei DQ
Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
[TBL] [Abstract][Full Text] [Related]
7. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
Houck P; Hemphill M; LaCroix S; Hirsh D; Cox N
Arch Intern Med; 1995 Mar; 155(5):533-7. PubMed ID: 7864709
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of primary structure of M-genes in remantadine-resistant and remantadine-sensitive strains of influenza virus A/FPV/Weybridge (H7N7) strains].
Karginov VA; Blinov VM; Safronov PF; Mamaev LV; Golovin SIa
Bioorg Khim; 1987 Dec; 13(12):1638-43. PubMed ID: 3450279
[TBL] [Abstract][Full Text] [Related]
9. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
[TBL] [Abstract][Full Text] [Related]
10. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
Du QS; Huang RB; Wang CH; Li XM; Chou KC
J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
[TBL] [Abstract][Full Text] [Related]
11. Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A.
Tataridis D; Fytas G; Kolocouris A; Fytas C; Kolocouris N; Foscolos GB; Padalko E; Neyts J; De Clercq E
Bioorg Med Chem Lett; 2007 Feb; 17(3):692-6. PubMed ID: 17113287
[TBL] [Abstract][Full Text] [Related]
12. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
Huang RB; Du QS; Wang CH; Chou KC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
[TBL] [Abstract][Full Text] [Related]
13. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
Nau JY
Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
[No Abstract] [Full Text] [Related]
14. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
[TBL] [Abstract][Full Text] [Related]
15. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
[TBL] [Abstract][Full Text] [Related]
16. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
[TBL] [Abstract][Full Text] [Related]
17. Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea.
Lee J; Song YJ; Park JH; Lee JH; Baek YH; Song MS; Oh TK; Han HS; Pascua PN; Choi YK
J Clin Microbiol; 2008 Nov; 46(11):3788-90. PubMed ID: 18845822
[TBL] [Abstract][Full Text] [Related]
18. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
19. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
[TBL] [Abstract][Full Text] [Related]
20. How does influenza virus a escape from amantadine?
Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]